Evidence map›Paper›PMID 38862978›Full record

ArticleHealth research policy and systems2024

Understanding contextual and practical factors to inform WHO recommendations on using chest imaging to monitor COVID-19 pulmonary sequelae: a qualitative study exploring stakeholders' perspective.

Gladys Honein-AbouHaidar, Cynthia Rizkallah, Imad Bou Akl, Gian Paolo Morgano, Tereza Vrbová, Emilie van Deventer, Maria Del Rosario Perez, Elie A Akl

Abstract read
In one paragraph

Article in Health research policy and systems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gladys Honein-AbouHaidarHariri School of Nursing, American University of Beirut, Beirut, Lebanon.
Cynthia RizkallahHariri School of Nursing, American University of Beirut, Beirut, Lebanon.
Imad Bou AklDepartment of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Gian Paolo MorganoDepartment of Health Research Methods, Evidence and Impact McMaster University, 1280 Main Street West, Hamilton, Canada.
Tereza VrbováCzech National Centre for Evidence-Based Healthcare and Knowledge Translation (CEBHC-KT), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Emilie van DeventerRadiation and Health Unit, Department of Environment, Climate Change and Health, World Health Organization, Geneva, Switzerland. vandeventere@who.int.
Maria Del Rosario PerezRadiation and Health Unit, Department of Environment, Climate Change and Health, World Health Organization, Geneva, Switzerland.
Elie A AklDepartment of Medicine, American University of Beirut, Riad-El-Solh, P.O. Box 11-0236, Beirut, 1107 2020, Lebanon. ea32@aub.edu.lb.ORCID http://orcid.org/0000-0002-3444-8618

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundA recommendation by the World Health Organization (WHO) was issued about the use of chest imaging to monitor pulmonary sequelae following recovery from COVID-19. This qualitative study aimed to explore the perspective of key stakeholders to understand their valuation of the outcome of the proposition, preferences for the modalities of chest imaging, acceptability, feasibility, impact on equity and practical considerations influencing the implementation of using chest imaging.

methodsA qualitative descriptive design using in-depth interviews approach. Key stakeholders included adult patients who recovered from the acute illness of COVID-19, and providers caring for those patients. The Evidence to Decision (EtD) conceptual framework was used to guide data collection of contextual and practical factors related to monitoring using imaging. Data analysis was based on the framework thematic analysis approach.

results33 respondents, including providers and patients, were recruited from 15 different countries. Participants highly valued the ability to monitor progression and resolution of long-term sequelae but recommended the avoidance of overuse of imaging. Their preferences for the imaging modalities were recorded along with pros and cons. Equity concerns were reported across countries (e.g., access to resources) and within countries (e.g., disadvantaged groups lacked access to insurance). Both providers and patients accepted the use of imaging, some patients were concerned about affordability of the test. Facilitators included post- recovery units and protocols. Barriers to feasibility included low number of specialists in some countries, access to imaging tests among elderly living in nursing homes, experience of poor coordination of care, emotional exhaustion, and transportation challenges driving to a monitoring site.

conclusionWe were able to demonstrate that there is a high value and acceptability using imaging but there were factors influencing feasibility, equity and some practical considerations associated with implementation. We had a few suggestions to be considered by the expert panel in the formulation of the guideline to facilitate its implementation such as using validated risk score predictive tools for lung complications to recommend the appropriate imaging modality and complementary pulmonary function test.

Indexed as

COVID-19Qualitative ResearchSARS-CoV-2World Health OrganizationAdultAgedFemaleHealth PersonnelHumansLungMaleMiddle AgedStakeholder ParticipationChest imagingCOVID-19Long COVIDPractice guidelinesQualitative research

Identifiers

PMID38862978
PMCPMC11167887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.